OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 131 filers reported holding OCULAR THERAPEUTIX INC in Q1 2022. The put-call ratio across all filers is 1.09 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $69 | -13.8% | 10,114 | -60.3% | 0.00% | -50.0% |
| Q3 2023 | $80 | -68.5% | 25,480 | -48.2% | 0.00% | -63.6% |
| Q2 2023 | $254 | -99.9% | 49,230 | -33.1% | 0.01% | -38.9% |
| Q3 2022 | $305,000 | +11.3% | 73,590 | +7.8% | 0.02% | -14.3% |
| Q2 2022 | $274,000 | +364.4% | 68,280 | +475.9% | 0.02% | +425.0% |
| Q1 2022 | $59,000 | -41.6% | 11,857 | +17.4% | 0.00% | -69.2% |
| Q3 2021 | $101,000 | – | 10,100 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 3,784,850 | $15,064,000 | 62.56% |
| Versant Venture Management, LLC | 2,215,384 | $8,817,228,000 | 4.36% |
| SV Health Investors, LLC | 628,236 | $2,500,000 | 1.54% |
| DELTEC ASSET MANAGEMENT LLC | 724,747 | $2,885,000 | 0.80% |
| Endurant Capital Management LP | 232,727 | $926,000 | 0.49% |
| NOTTINGHAM ADVISORS, INC. | 146,946 | $1,011,000 | 0.15% |
| JGP Global Gestao de Recursos Ltda. | 12,568 | $50,000 | 0.06% |
| Man Group plc | 1,187,508 | $4,726,000 | 0.02% |
| Dynamic Technology Lab Private Ltd | 21,077 | $84,000 | 0.02% |
| NewEdge Advisors, LLC | 36,250 | $144,000 | 0.01% |